Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 111 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
Bae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZ, CRISP and HALT PKD Consortium
Clin J Am Soc Nephrol, 17(3):374-384, 25 Feb 2022
Cited by: 3 articles | PMID: 35217526 | PMCID: PMC8975034
Add to export list Free full text in Europe PMC
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audrézet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, [...] Harris PC
Am J Hum Genet, 109(1):136-156, 09 Dec 2021
Cited by: 56 articles | PMID: 34890546 | PMCID: PMC8764120
Add to export list Free full text in Europe PMC
PKD1 Compared With PK D2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.
Steele C, You Z, Gitomer BY, Brosnahan GM, Abebe KZ, Braun WE, Chapman AB, Harris PC, Perrone RD, Steinman TI, Torres VE, Yu ASL, Chonchol M, Nowak KL
Kidney Int Rep, 7(1):117-120, 07 Oct 2021
Cited by: 2 articles | PMID: 35005320 | PMCID: PMC8720657
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study.
Raines NH, Ganatra S, Nissaisorakarn P, Pandit A, Morales A, Asnani A, Sadrolashrafi M, Maheshwari R, Patel R, Bang V, Shreyder K, Brar S, Singh A, Dani SS, Knapp S, Poyan Mehr A, Brown RS, Zeidel ML, Bhargava R, [...] Parikh SM
Kidney360, 2(1):33-41, 20 Nov 2020
Cited by: 16 articles | PMID: 35368823 | PMCID: PMC8785722
Add to export list Free full text in Europe PMC
Mineral bone disease in autosomal dominant polycystic kidney disease.
Gitomer B, Pereira R, Salusky IB, Stoneback JW, Isakova T, Cai X, Dalrymple LS, Ofsthun N, You Z, Malluche HH, Maddux F, George D, Torres V, Chapman A, Steinman TI, Wolf M, Chonchol M
Kidney Int, 99(4):977-985, 11 Sep 2020
Cited by: 16 articles | PMID: 32926884 | PMCID: PMC7993988
Add to export list Free full text in Europe PMC
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, HALT PKD and CRISP Study Investigators, Harris PC
JCI Insight, 5(15):138724, 06 Aug 2020
Cited by: 36 articles | PMID: 32634120 | PMCID: PMC7455088
Add to export list Free full text in Europe PMC
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP, HALT PKD Consortium
J Am Soc Nephrol, 31(7):1640-1651, 02 Jun 2020
Cited by: 19 articles | PMID: 32487558 | PMCID: PMC7350997
Add to export list Free full text in Europe PMC
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
Hopp K, Cornec-Le Gall E, Senum SR, Te Paske IBAW, Raj S, Lavu S, Baheti S, Edwards ME, Madsen CD, Heyer CM, Ong ACM, Bae KT, Fatica R, Steinman TI, Chapman AB, Gitomer B, Perrone RD, Rahbari-Oskoui FF, Torres VE, [...] Harris PC
Kidney Int, 97(2):370-382, 09 Oct 2019
Cited by: 37 articles | PMID: 31874800 | PMCID: PMC7218796
Add to export list Free full text in Europe PMC
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB
Kidney Int Rep, 4(12):1742-1748, 24 Aug 2019
Cited by: 4 articles | PMID: 31844811 | PMCID: PMC6895647
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.
Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, Betensky RA, Steinman TI, Thadhani RI, McMahon GM, Stillman IE, Rennke HG, Waikar SS
J Am Soc Nephrol, 29(8):2213-2224, 04 Jun 2018
Cited by: 96 articles | PMID: 29866798 | PMCID: PMC6065095
Add to export list Free full text in Europe PMC
Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease.
Dad T, Abebe KZ, Bae KT, Comer D, Torres VE, Czarnecki PG, Schrier RW, Steinman TI, Moore CG, Chapman AB, Kaya D, Tao C, Braun WE, Winklhofer FT, Brosnahan G, Hogan MC, Miskulin DC, Rahbari Oskoui F, Flessner MF, Perrone RD
Kidney Int Rep, 3(3):619-624, 06 Jan 2018
Cited by: 5 articles | PMID: 29854969 | PMCID: PMC5976807
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.
Cornec-Le Gall E, Chebib FT, Madsen CD, Senum SR, Heyer CM, Lanpher BC, Patterson MC, Albright RC, Yu AS, Torres VE, HALT Progression of Polycystic Kidney Disease Group Investigators, Harris PC
Am J Kidney Dis, 72(2):302-308, 01 Feb 2018
Cited by: 21 articles | PMID: 29395486 | PMCID: PMC6057824
Add to export list Free full text in Europe PMC
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VE, HALT-PKD Trial Investigators
Am J Kidney Dis, 71(5):666-676, 03 Jan 2018
Cited by: 23 articles | PMID: 29306517 | PMCID: PMC5916329
Add to export list Free full text in Europe PMC
ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.
Braun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, Grantham JJ, Flessner MF, Schrier RW
Am J Kidney Dis, 71(2):294-296, 02 Dec 2017
Cited by: 3 articles | PMID: 29203126 | PMCID: PMC6267804
Add to export list Free full text in Europe PMC
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators
Curr Hypertens Rev, 14(1):39-47, 01 Jan 2018
Cited by: 10 articles | PMID: 29564978 | PMCID: PMC6063360
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M
J Am Soc Nephrol, 29(2):571-578, 08 Nov 2017
Cited by: 80 articles | PMID: 29118087 | PMCID: PMC5791072
Add to export list Free full text in Europe PMC
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Chonchol M, Gitomer B, Isakova T, Cai X, Salusky I, Pereira R, Abebe K, Torres V, Steinman TI, Grantham JJ, Chapman AB, Schrier RW, Wolf M
Clin J Am Soc Nephrol, 12(9):1461-1469, 13 Jul 2017
Cited by: 17 articles | PMID: 28705885 | PMCID: PMC5586583
Add to export list Free full text in Europe PMC
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
Irazabal MV, Abebe KZ, Bae KT, Perrone RD, Chapman AB, Schrier RW, Yu AS, Braun WE, Steinman TI, Harris PC, Flessner MF, Torres VE, HALT Investigators
Nephrol Dial Transplant, 32(11):1857-1865, 01 Nov 2017
Cited by: 34 articles | PMID: 27484667 | PMCID: PMC5837227
Add to export list Free full text in Europe PMC
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF
Kidney Int, 91(2):493-500, 16 Dec 2016
Cited by: 50 articles | PMID: 27993381 | PMCID: PMC5237414
Add to export list Free full text in Europe PMC
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
Brosnahan GM, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VE, HALT PKD Investigators
Curr Hypertens Rev, 13(2):109-120, 01 Jan 2017
Cited by: 23 articles | PMID: 28460625 | PMCID: PMC5688015
Add to export list Free full text in Europe PMC
TECHNOLOGY AND THE FUTURE OF KIDNEY CARE.
Freedman BS, Zeidel ML, Steinman TI
Nephrol News Issues, 30(12):24-28, 01 Nov 2016
Cited by: 0 articles | PMID: 30645802
Add to export list
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, [...] HALT PKD and CRISP Investigators
J Am Soc Nephrol, 27(9):2872-2884, 28 Jan 2016
Cited by: 110 articles | PMID: 26823553 | PMCID: PMC5004648
Add to export list Free full text in Europe PMC
Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.
Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad AF, Li MK, Hughes MR, Werff RV, Peters DT, Lu J, Baccei A, Siedlecki AM, Valerius MT, Musunuru K, McNagny KM, Steinman TI, Zhou J, [...] Bonventre JV
Nat Commun, 6:8715, 23 Oct 2015
Cited by: 376 articles | PMID: 26493500 | PMCID: PMC4620584
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
iPS cell technology: Future impact on renal care.
Freedman BS, Steinman TI
Nephrol News Issues, 29(9):18, 20-1, 01 Aug 2015
Cited by: 1 article | PMID: 26454909 | PMCID: PMC4918073
Add to export list Free full text in Europe PMC
Closeout of the HALT-PKD trials.
Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC
Contemp Clin Trials, 44:48-55, 29 Jul 2015
Cited by: 1 article | PMID: 26231556 | PMCID: PMC4732941
Add to export list Free full text in Europe PMC

1-25 of 111 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.

Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.

PKD1 Compared With PK D2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.

Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study.

Mineral bone disease in autosomal dominant polycystic kidney disease.

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.

Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.

Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.

The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.

Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease.

The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.

Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?

Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.

Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.

Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.

Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.

TECHNOLOGY AND THE FUTURE OF KIDNEY CARE.

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids.

iPS cell technology: Future impact on renal care.

Closeout of the HALT-PKD trials.

Partnerships & funding